Navigation Links
Protein ZEB1 promotes breast tumor resistance to radiation therapy
Date:8/4/2014

Twist, Snail, Slug. They may sound like words in a children's nursery rhyme, but they are actually the exotic names given to proteins that can generate cells with stem cell-like properties that have the ability to form diverse types of tissue.

One protein with the even more out-there name of ZEB1 (zinc finger E-box binding homeobox 1), is now thought to keep breast cancer cells from being successfully treated with radiation therapy, according to a study at The University of Texas MD Anderson Cancer Center in Houston.

Li Ma, Ph.D., an assistant professor of experimental radiation oncology at MD Anderson, reported in this month's issue of Nature Cell Biology that ZEB1 may actually be helping breast tumor cells repair DNA damage caused by radiation treatment by ramping up a first-line of defense known as DNA damage response pathway.

"Radiation therapy causes cell death by inducing DNA ' breaks'," said Ma. "The rationale for treating tumors with radiation without damaging normal tissues is that, compared with normal cells, tumor cells are actively dividing and often have defects in DNA damage repair machinery."

Tumor cells are thus less able to repair DNA damage. But not always. Sometimes the body produces tumor cells resistant to radiation. They are somehow able to "turn on" the DNA damage response apparatus. Until now, the question has always been how?

Ma's team has demonstrated that the wily tumor cell's ability to push the panic button at the last second can be triggered by ZEB1's penchant for launching an operation that generates cancer stem cells.

"The cancer stem cells have been shown to promote radioresistance through activation of the DNA damage response system," said Ma. "Our studies have shown that ZEB1 can induce a process known as epithelial-mesenchymal transition (EMT) which allows certain tumor to acquire cancer stem cell properties including radioresistance."

EMT is one way the body r
'/>"/>

Contact: Ron Gilmore
rlgilmore1@mdanderson.org
713-745-1898
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Rare developmental disorder linked to tumor-suppressing protein, Stanford researchers find
2. Breakthrough in understanding of important blood protein
3. U-M researchers find protein that fuels repair of treatment-resistant cancer cells
4. Study Finds Common Blood Protein May Predict Mesothelioma Survival, Reports Surviving Mesothelioma
5. Research may explain how foremost anticancer guardian protein learned to switch sides
6. ProCare Protein Check Tests Surgical Instruments to Verify Effective Cleaning
7. Bariatric Eating Announces Three New Protein Shake Flavors
8. Manipulating key protein in the brain holds potential against obesity and diabetes
9. Freeslate Featured in BioProcess International Article Discussing Challenges and Solutions to Highly Concentrated Protein Formulations
10. Researchers unlock the protein puzzle
11. Described novel regulator of a protein inactive in over 50 percent of human tumors
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Protein ZEB1 promotes breast tumor resistance to radiation therapy
(Date:3/3/2015)... 03, 2015 US Air Purifiers LLC ... purification systems, is pleased to announce that all Rabbit brand ... interruption related to the west coast port strikes. This news ... the corner. , The port strikes, which ... slow fourth quarter economic growth by as much as 1%, ...
(Date:3/3/2015)... March 03, 2015 The first week ... National Sleep Foundation. The event brings recognition to a ... , According to the Centers for Disease ... of one form or another. Too little or unrestful ... of physical illness and depression, and even a higher ...
(Date:3/3/2015)... 03, 2015 Today is International Ear ... using the occasion to applaud and promote the launch ... World Health Organization (WHO) for stemming the threat of ... encourage young people to practice safe listening when they ... concerts or sporting events, or engaging in other forms ...
(Date:3/3/2015)... 2015 The number of couples experiencing ... about 15%. This increases to 50% by the time ... JL, Yuzpe AA, et al. Estimating the prevalence of ... Jason Hitkari, a reproductive endocrinologist and co-director at Olive ... and clinical director and founder of Acubalance Wellness Centre ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 -- vRad ( ... radiology practice, today announced that Arlene Sussman, MD, a ... host a live webinar to explore how telemedicine best ... breast imaging services for women virtually anywhere. Click ... Imaging Service Line” on March 4, 2015 at 1:00 ...
Breaking Medicine News(10 mins):Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 2Health News:Medicationdiscountcard.com recognizes sleep awareness week with discounts on sleep meds including Ambien, Lunesta, and Sonata 3Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 2Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 3Health News:Latest vRad Webinar: Building World-Class Breast Imaging Services Virtually Anywhere with Telemedicine Best Practices 4
... But some mental-health experts dispute the findings , , TUESDAY, ... as Prozac are widely prescribed for people with varying ... those with the most severe depression, a new study ... antidepressants, they also get better when they take a ...
... Wealthy Suburbanites Equal High Demand for Medical ... HealthLeaders-InterStudy, NASHVILLE, Tenn., Feb. 27 HealthLeaders-InterStudy, ... health,systems, eager to gain an advantage in the ... new facilities and completing mergers.,According to the newly ...
... Sooner, ASPS Study Says, ARLINGTON HEIGHTS, Ill., ... Americans, skin may keep its youthful appearance longer,than ... show,facial aging in the outer corner of the ... Reconstructive Surgery(R) (PRS), the,official medical journal of the ...
... Satisfaction with GlaxoSmithKline,s Advair and,Boehringer Ingelheim/Pfizer,s Spiriva, ... Drug, According to a New Report from ... Decision Resources, one of the,world,s leading ... and,healthcare issues, finds that surveyed physicians indicate ...
... Materials, Fuel, ... Food, ... ),today announced leadership changes to strengthen its leading biotechnology,position and better ... materials, food, feed and fuel markets., "Across its business segments, ...
... Center to Provide Increased High-Performance ... to Korean Industry and Academia, SOUTHPOINTE, Pa., ... a global innovator of simulation software and technologies,designed ... Korean Institute of Science and Technology Information (KISTI), ...
Cached Medicine News:Health News:Only Severely Depressed Benefit From Antidepressants: Study 2Health News:Mergers and New Facilities Abound in Washington, D.C. Suburbs 2Health News:African Americans Show Facial Aging in Eyes Earlier Than Caucasians 2Health News:A Once-Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD-Related Inflammation Could Achieve Blockbuster Status 2Health News:DuPont Strengthens Leading Biotechnology Position with Leadership Changes 2Health News:DuPont Strengthens Leading Biotechnology Position with Leadership Changes 3Health News:DuPont Strengthens Leading Biotechnology Position with Leadership Changes 4Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 2Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 3Health News:KISTI Selects ANSYS as a Key Supplier in Engineering Simulation 4
(Date:3/3/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/lbvqqr/global_ultrasound ) ... Ultrasound Equipment Market 2015-2019" report to their ... Ultrasound Equipment market to grow at a CAGR ... Ultrasound equipment are used to examine organs using ... by cardiologists, radiologists, surgeons, obstetricians, and many other ...
(Date:3/3/2015)... 2015  Cyberonics, Inc. (NASDAQ: CYBX ), ... and management of epilepsy, today announced it will participate ... 11, 2015, in Miami . ... Executive Officer, will speak at 1:05 PM Eastern Time.  ... format, and no formal materials will be presented.  A ...
(Date:3/3/2015)... BETHESDA, Md. , March 3, 2015 /PRNewswire/-- ViaCyte, Inc., ... cell-derived islet replacement therapy for the treatment of diabetes ... Eugene Brandon , Director of Strategic Relations and ... summit showcases the latest in type 1 diabetes management ... are as follows: , , , Title:   ...
Breaking Medicine Technology:Global Ultrasound Equipment Market 2015-2019: Rise in Number of MI Diagnostic Procedures with GE Healthcare, Phillips Healthcare, Siemens Healthcare & Toshiba Medical Systems Dominating 2ViaCyte to Present at JDRF TypeOneNation Research Summit 2
... , April 26, 2010 Thanks to promising,commercial debut of ... Technologies service offer (fully,integrated and automated patient/product tracking and supply chain) IMPLANET,S.A. ... ). , , , ... IMPLANET is proud to welcome a reference new institutional investor,CM-CIC Private ...
... April 26 Sirion Therapeutics, Inc., a privately ... gel) 0.15% is now commercially available.  Zirgan™, which was approved ... 2009 , is a topical ophthalmic antiviral indicated for the ... , , ...
Cached Medicine Technology:IMPLANET Raises Additional EUR 8 Million (USD 11 Million) to Fuel Deployment 2Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 2Sirion Therapeutics Announces Availability of Zirgan(TM) (ganciclovir ophthalmic gel) 0.15% for Ocular Herpes 3
Gentle curve facilitates less traumatic removal from eye. Increased length ideal for myopic eyes...
Great for small incisions and excision needs...
Cannula: .90mm x 28mm (20 G x 1 1/8 in) Handle: 9.3cm (3 5/8 in) long, Flute, .90 x 28mm, vacuum handle [Charles]...
2.5mm...
Medicine Products: